(NYSE: BAK) Braskem Sa's forecast annual revenue growth rate of 7.08% is forecast to beat the US Chemicals industry's average forecast revenue growth rate of 3.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.39%.
Braskem Sa's revenue in 2024 is $13,864,243,614.On average, 2 Wall Street analysts forecast BAK's revenue for 2024 to be $11,783,449,273,571, with the lowest BAK revenue forecast at $11,644,256,785,754, and the highest BAK revenue forecast at $11,922,641,761,387. On average, 2 Wall Street analysts forecast BAK's revenue for 2025 to be $12,908,540,717,616, with the lowest BAK revenue forecast at $12,553,671,622,390, and the highest BAK revenue forecast at $13,263,409,812,843.
In 2026, BAK is forecast to generate $13,208,235,058,652 in revenue, with the lowest revenue forecast at $13,208,235,058,652 and the highest revenue forecast at $13,208,235,058,652.